Correlation Between Nuvectis Pharma and Syndax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Nuvectis Pharma and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvectis Pharma and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvectis Pharma and Syndax Pharmaceuticals, you can compare the effects of market volatilities on Nuvectis Pharma and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvectis Pharma with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvectis Pharma and Syndax Pharmaceuticals.
Diversification Opportunities for Nuvectis Pharma and Syndax Pharmaceuticals
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Nuvectis and Syndax is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and Nuvectis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvectis Pharma are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of Nuvectis Pharma i.e., Nuvectis Pharma and Syndax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Nuvectis Pharma and Syndax Pharmaceuticals
Given the investment horizon of 90 days Nuvectis Pharma is expected to under-perform the Syndax Pharmaceuticals. In addition to that, Nuvectis Pharma is 2.18 times more volatile than Syndax Pharmaceuticals. It trades about -0.08 of its total potential returns per unit of risk. Syndax Pharmaceuticals is currently generating about -0.07 per unit of volatility. If you would invest 1,921 in Syndax Pharmaceuticals on August 27, 2024 and sell it today you would lose (248.00) from holding Syndax Pharmaceuticals or give up 12.91% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nuvectis Pharma vs. Syndax Pharmaceuticals
Performance |
| Timeline |
| Nuvectis Pharma |
| Syndax Pharmaceuticals |
Nuvectis Pharma and Syndax Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nuvectis Pharma and Syndax Pharmaceuticals
The main advantage of trading using opposite Nuvectis Pharma and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvectis Pharma position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
| Syndax Pharmaceuticals vs. Eliem Therapeutics | Syndax Pharmaceuticals vs. HCW Biologics | Syndax Pharmaceuticals vs. Scpharmaceuticals | Syndax Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |